OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.115
+0.015 (1.36%)
Feb 21, 2025, 4:00 PM EST - Market closed
OKYO Pharma Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for OKYO Pharma stock has a target of 7.00, which predicts an increase of 527.80% from the current stock price of 1.12.
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for OKYO Pharma is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +527.80% | Feb 18, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +527.80% | Feb 14, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +527.80% | Feb 10, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +527.80% | Oct 24, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +527.80% | Oct 16, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.17
from -0.57
EPS Next Year
n/a
from -0.17
Revenue Forecast
Revenue | 2025 |
---|---|
High | n/a |
Avg | n/a |
Low | n/a |
Revenue Growth
Revenue Growth | 2025 |
---|---|
High | - |
Avg | - |
Low | - |
EPS Forecast
EPS | 2025 |
---|---|
High | -0.18 |
Avg | -0.17 |
Low | -0.17 |
EPS Growth
EPS Growth | 2025 |
---|---|
High | - |
Avg | - |
Low | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.